As Britain’s departure date from the European Union approaches, drugmakers are preparing for potential changes to regulatory procedures and border controls.

Pharma companies are more compliant in posting results compared to universities.

Some researchers have already been negatively affected by the U.K.’s decision to leave the European Union, though opinions on the eventual outcome remain mixed.

The country will opt-out of growing genetically modified foods that have been approved for cultivation in the European Union.

The European Parliament rejected a proposal designed to fund the construction of new fishing boats, instead opting to fund a project that aims to curtail overfishing.